Profile data is unavailable for this security.
About the company
BPH Global Limited is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company’s product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.
- Revenue in AUD (TTM)352.38k
- Net income in AUD-1.49m
- Incorporated1984
- Employees31.00
- LocationBPH Global LtdBlock ArcadeOffice 324, Level 3, 96 Elizabeth St,MELBOURNE 3000AustraliaAUS
- Phone+61 28072-1400
- Fax+61 28072-1400
- Websitehttps://scu.com.sg/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hexima Ltd | 0.00 | -503.83k | 2.17m | -- | -- | -- | -- | -- | -0.0246 | -0.0246 | 0.00 | 0.0091 | 0.00 | -- | -- | -- | -26.34 | -72.86 | -28.49 | -144.87 | -- | -- | -- | -335.94 | -- | -- | 0.00 | -- | -100.00 | -- | 46.05 | -- | -- | -- |
| Argent BioPharma Ltd | 180.56k | -17.84m | 4.73m | -- | -- | -- | -- | 26.17 | -0.3292 | -0.3292 | 0.0032 | -0.1196 | 0.0272 | 0.2721 | 0.4238 | -- | -269.25 | -135.49 | -- | -380.42 | 24.06 | -45.51 | -9,882.75 | -764.45 | 0.1752 | -321.38 | -- | -- | -79.74 | -38.66 | -1.79 | -- | -70.28 | -- |
| Inhalerx Ltd | 837.55k | -1.33m | 5.42m | -- | -- | -- | -- | 6.47 | -0.006 | -0.006 | 0.0037 | -0.0041 | 0.8301 | -- | 2.50 | -- | -131.43 | -73.85 | -- | -100.32 | -- | -- | -158.33 | -369.19 | -- | -- | -- | -- | -66.38 | 21.67 | 16.21 | -- | -- | -- |
| BPH Global Ltd | 352.38k | -1.49m | 5.56m | 31.00 | -- | -- | -- | 15.78 | -0.0026 | -0.0026 | 0.0006 | -0.0014 | 0.8548 | 3.49 | 2.27 | -- | -360.76 | -76.32 | -- | -214.32 | 6.86 | 17.08 | -422.04 | -156.56 | 0.1995 | -43.14 | -- | -- | 220.43 | -13.56 | 24.87 | -- | -- | -- |
| Invion Ltd | 0.00 | -8.81m | 7.11m | 8.00 | -- | 0.8538 | -- | -- | -0.1183 | -0.1183 | 0.00 | 0.0972 | 0.00 | -- | -- | -- | -70.63 | -29.16 | -77.64 | -30.88 | -- | -- | -- | -147.34 | -- | -- | 0.00 | -- | -100.00 | -- | -56.50 | -- | -- | -- |
| Biotron Ltd | 0.00 | -318.57k | 8.11m | 4.00 | -- | 7.21 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -43.23 | -86.63 | -206.95 | -112.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 90.73 | -- | -- | -- |
| Vectus Biosystems Ltd | 18.77k | -1.78m | 8.28m | -- | -- | -- | -- | 441.24 | -0.0334 | -0.0334 | 0.0004 | -0.0048 | 0.0134 | -- | 0.0266 | -- | -126.57 | -79.19 | -247.24 | -189.44 | -- | -- | -9,468.62 | -10,165.01 | 0.9301 | -554.06 | -- | -- | -75.58 | 73.61 | 23.99 | -- | -- | -- |
| Percheron Therapeutics Ltd | 371.10k | -14.92m | 8.70m | 8.00 | -- | 0.8696 | -- | 23.44 | -0.0149 | -0.0149 | 0.0004 | 0.0092 | 0.0275 | -- | 0.2824 | -- | -110.67 | -79.28 | -153.98 | -96.61 | -- | -- | -4,021.00 | -3,694.96 | -- | -1,093.50 | 0.0026 | -- | -39.71 | 64.80 | -25.19 | -- | -6.74 | -- |
| Invex Therapeutics Ltd | 461.52k | -476.87k | 9.02m | -- | -- | 1.72 | -- | 19.54 | -0.0063 | -0.0063 | 0.0061 | 0.0698 | 0.0797 | -- | 4.92 | -- | -8.23 | -15.04 | -8.72 | -15.74 | -- | -- | -103.33 | -419.12 | -- | -- | 0.00 | -- | -72.92 | 22.74 | 70.95 | -- | -- | -- |
| Chimeric Therapeutics Ltd | 3.97m | -10.43m | 11.05m | -- | -- | 2.68 | -- | 2.78 | -0.0071 | -0.0071 | 0.0029 | 0.0009 | 0.2154 | -- | 1.73 | -- | -56.62 | -66.67 | -171.92 | -112.02 | 78.66 | -- | -262.83 | -2,013.07 | -- | -62.30 | 0.7162 | -- | -- | -- | 16.76 | -- | -- | -- |
